Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Net Equity Issued and Repurchased (2024)

Updated

Pharming (PHAR) recorded Net Equity Issued and Repurchased of $21.28 million in FY2023.

Analysis

Pharming (PHAR) Net Equity Issued and Repurchased (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 138.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -9.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -346.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 134.92 Mn
API Access

Pharming Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PHAR&period=max&api_key=YOUR_API_KEY